Leonard Reyno

Leonard Reyno

Company: Pionyr Immunotherapeutics Inc

Job title: CMO


PY314: Targeting Trem2 in CPI Resistant Cancers 1:30 pm

Trem2 is widely expressed in infiltrating macrophages multiple solid tumors. PY314 is a monoclonal antibody that depletes targeted macrophages via ADCC/ADCP PY314 active in multiple preclinical CPI resistant models Clinical trial in progress evaluating PY314 alone and in combination with pembrolizumabRead more

day: Clinical Development – Day 2 pm

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.